Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Cash Flow from Financing Activities ₹23 Cr₹-44 Cr₹-30 Cr₹-64 Cr₹-16 Cr

What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES is ₹23 Cr based on Mar2023 Consolidated results.
Year Cash Flow from Financing Activities
Mar2023₹23 Cr
Mar2022₹-44 Cr
Mar2021₹-30 Cr
Mar2020₹-64 Cr
Mar2019₹-16 Cr

How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2023 ₹23 Cr
Positive
Mar2022 ₹-44 Cr
Negative
Mar2021 ₹-30 Cr
Negative
Mar2020 ₹-64 Cr
Negative
Mar2019 ₹-16 Cr -

Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹3,110.8 Cr 2.7% -0.6% 2.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

2.7%

-0.6%

2.7%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses